A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2.
Nakai Y, Isayama H, Ijichi H, Sasaki T, Takahara N, Ito Y, Matsubara S, Uchino R, Yagioka H, Arizumi T, Hamada T, Miyabayashi K, Mizuno S, Yamamoto K, Kogure H, Yamamoto N, Hirano K, Sasahira N, Tateishi K, Tada M, Koike K.
Nakai Y, et al. Among authors: ijichi h.
Invest New Drugs. 2013 Oct;31(5):1294-9. doi: 10.1007/s10637-013-9972-5. Epub 2013 May 21.
Invest New Drugs. 2013.
PMID: 23690239
Clinical Trial.